Stock Scorer
Stock Board CompareNew Screen
Donate
…
Report Measures Companies
Sign in

Bioceres Crop Solutions Corp. (BIOX)

Every figure this model derived for BIOX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 3,505,992 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 12,579,828 CashAndCashEquivalents 2025-12-31
current assets 294,280,054 CurrentAssets 2025-12-31
current liabilities 328,636,804 CurrentLiabilities 2025-12-31
equity 76,406,326 EquityAttributableToOwnersOfParent 2025-12-31
interest expense 31,311,820 FinanceCosts 2025-12-31
ocf 81,871,862 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 285,074,319 RevenueFromContractsWithCustomers 2025-12-31
sbc 3,577,636 AdjustmentsForSharebasedPayments 2025-09-30

The ratios

The figures themselves rather than their scores — what somebody looking up BIOX on one particular measure came for.

RatioValue
cash operating margin2.51
current ratio0.9
current ratio reported0.9
dilution pct-0.41
ev owner earnings1.89
ev sales0.5
fcf margin27.49
growth cv1.58
interest cover-0.07
net debt ebitda34.22
operating margin-0.78
owner earnings margin26.23
revenue growth-28.71
revenue growth per share-28.42
roic-0.89
rule of 40-29.49
sbc pct revenue1.25

Everything else this filing tags

296 more elements from BIOX's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.

ElementNewestAs of PeriodsUnit
Assets560,361,5412025-12-31 45USD
EquityAndLiabilities560,361,5412025-12-31 45USD
Liabilities453,745,2402025-12-31 45USD
NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts367,911,8972025-06-30 20USD
NoncurrentAssets266,081,4872025-12-31 45USD
LiabilitiesArisingFromFinancingActivities262,355,6452025-06-30 23USD
ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity-190,367,7062025-12-31 64USD
ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects-190,367,7062025-12-31 60USD
ComprehensiveIncome-189,961,8822025-12-31 68USD
ProfitLoss-189,917,7632025-12-31 68USD
ComprehensiveIncomeFromDiscontinuedOperations-180,701,8732025-12-31 4USD
ComprehensiveIncomeFromDiscontinuedOperationsAttributableToOwnersOfParent-180,701,8732025-12-31 4USD
IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent-180,701,8732025-12-31 4USD
ProfitLossFromDiscontinuedOperations-180,701,8732025-12-31 4USD
ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity-180,701,8732025-12-31 4USD
ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects-180,701,8732025-12-31 4USD
GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation-179,008,3412025-12-31 2USD
TradeAndOtherCurrentReceivables158,385,2292025-09-30 41USD
CurrentTradeReceivables154,931,5232025-12-31 23USD
FinancialLiabilities146,012,2852018-06-30 1USD
Revenue142,932,6422025-12-31 61USD
NoncurrentLiabilities125,108,4362025-12-31 45USD
Equity106,616,3012025-12-31 81USD
ShorttermBorrowings90,063,2282025-12-31 45USD
TradeAndOtherCurrentPayables89,408,4302025-12-31 45USD
DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsOtherThanGoodwill89,149,0472025-12-31 1USD
IntangibleAssetsOtherThanGoodwill87,289,8012025-12-31 58USD
CostOfSales85,515,4672025-12-31 68USD
TradeAndOtherCurrentPayablesToTradeSuppliers78,721,0932025-12-31 45USD
Inventories64,789,5452025-12-31 45USD
WeightedAverageShares63,477,1132025-12-31 66shares
AdjustedWeightedAverageShares63,428,1672025-09-30 58shares
InventoriesTotal63,324,9362025-12-31 87USD
PropertyPlantAndEquipment61,085,5792025-12-31 58USD
GrossProfit57,417,1752025-12-31 53USD
AmountsPayableRelatedPartyTransactions56,456,5802025-12-31 45USD
ShorttermEmployeeBenefitsExpense53,339,4962025-06-30 26USD
RepaymentsOfBorrowingsClassifiedAsFinancingActivities52,404,1352025-12-31 48USD
NoncurrentPayables51,650,9422025-12-31 14USD
NoncurrentPayablesToRelatedParties51,650,9422025-12-31 5USD
CashFlowsFromUsedInFinancingActivities-46,702,4422025-12-31 48USD
CashFlowsFromUsedInFinancingActivitiesContinuingOperations-45,636,1132025-12-31 2USD
NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners42,363,5632025-12-31 1USD
ProceedsFromIssueOfPreferenceShares42,000,0012016-12-31 1USD
IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities41,562,1252025-06-30 16USD
InvestmentsInSubsidiariesJointVenturesAndAssociates39,371,2642025-06-30 23USD
InvestmentAccountedForUsingEquityMethod38,732,6122025-12-31 28USD
CashFlowsFromUsedInOperatingActivitiesContinuingOperations37,470,8392025-12-31 2USD
Goodwill36,073,6832025-12-31 45USD
SellingGeneralAndAdministrativeExpense34,327,6502025-12-31 68USD
IntangibleAssetsWithIndefiniteUsefulLife34,200,0002024-03-31 5USD
LongtermBorrowings34,155,9632025-12-31 45USD
NoncontrollingInterests30,209,9752025-12-31 45USD
DeferredTaxLiabilities27,393,7932025-12-31 45USD
LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale27,363,5632025-12-31 1USD
NetDeferredTaxLiabilities24,994,5692022-06-30 8USD
OtherNoncurrentReceivables24,374,6862025-12-31 45USD
NoncurrentPortionOfNoncurrentBondsIssued23,529,7112025-12-31 43USD
BondsIssued23,353,0762025-12-31 45USD
AmountsReceivableRelatedPartyTransactions23,342,5342025-12-31 35USD
DeferredTaxLiabilityAsset-21,872,8422025-12-31 79USD
AdjustmentsForFinanceCosts20,835,3862025-12-31 48USD
IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges-19,004,7712025-12-31 48USD
OtherProvisions18,897,4892025-06-30 27USD
ProfitLossFromOperatingActivities17,207,8902025-12-31 68USD
ProceedsFromBorrowingsClassifiedAsFinancingActivities17,012,4582025-12-31 48USD
FinanceIncomeCost-16,118,1302025-12-31 52USD
OtherCurrentReceivables15,343,6832025-12-31 45USD
IssueOfEquity15,000,0002021-06-30 12USD
InterestExpenseOnOtherFinancialLiabilities14,603,8632025-12-31 54USD
PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets14,330,8922019-06-30 3USD
ShorttermInvestmentsClassifiedAsCashEquivalents13,206,9342025-06-30 19USD
AdjustmentsForDecreaseIncreaseInInventories12,639,7052025-12-31 33USD
ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets12,331,3902022-06-30 6USD
CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices12,191,5322025-12-31 45USD
DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment12,171,9002025-12-31 1USD
PurchaseOfAvailableforsaleFinancialAssets11,873,6962024-03-31 19USD
ProfessionalFeesExpense11,342,9042025-06-30 26USD
CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition11,064,6832025-12-31 81USD
RightofuseAssets10,975,6522025-12-31 38USD
UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised10,900,0002025-06-30 1USD
LeaseLiabilities10,883,1022025-12-31 54USD
Borrowings10,400,0002020-06-30 1USD
ComprehensiveIncomeFromContinuingOperationsAttributableToOwnersOfParent-9,695,9902025-12-31 4USD
IncomeFromContinuingOperationsAttributableToOwnersOfParent-9,665,8332025-12-31 4USD
ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity-9,665,8332025-12-31 4USD
ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects-9,665,8332025-12-31 4USD
AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables9,303,1352025-12-31 48USD
CurrentTaxExpenseIncome9,297,0652025-12-31 54USD
ComprehensiveIncomeFromContinuingOperations-9,260,0092025-12-31 4USD
ProfitLossFromContinuingOperations-9,215,8902025-12-31 4USD
Cash9,173,1592025-12-31 40USD
IssueOfConvertibleInstruments9,109,5162023-06-30 12USD
AdditionalProvisionsOtherProvisions9,007,2122025-06-30 20USD
IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations-8,847,7202025-12-31 2USD
NoncurrentLeaseLiabilities8,118,0302025-12-31 40USD
ComprehensiveIncomeAttributableToOwnersOfParent-7,650,4352025-09-30 64USD
AllowanceAccountForCreditLossesOfFinancialAssets7,538,5772024-03-31 19USD
ProfitLossAttributableToOwnersOfParent-7,327,8852025-09-30 64USD
ImpairmentLossRecognisedInProfitOrLossTradeReceivables7,123,7162025-06-30 22USD
InterestPaidClassifiedAsFinancingActivities6,982,9452025-12-31 33USD
IncreaseDecreaseThroughExerciseOfWarrantsEquity6,849,4682021-06-30 6USD
AdjustmentsForDecreaseIncreaseInTradeAccountReceivable-6,827,0572025-12-31 48USD
AmortisationIntangibleAssetsOtherThanGoodwill6,660,4382025-12-31 34USD
CurrentTaxLiabilities6,428,6972025-12-31 45USD
DeferredIncomeClassifiedAsCurrent6,277,3132021-06-30 13USD
ResearchAndDevelopmentExpense5,999,3792025-12-31 68USD
CurrentDepositsFromCustomers5,895,3132022-06-30 14USD
CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax5,847,2582025-12-31 45USD
CurrentAdvancesToSuppliers5,834,1582025-06-30 24USD
CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations-5,704,9512025-12-31 2USD
AdjustmentsForIncomeTaxExpense5,588,3942025-12-31 48USD
IncomeTaxExpenseContinuingOperations5,588,3942025-12-31 68USD
GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets-5,558,0132025-12-31 50USD
DeferredTaxAssets5,520,9512025-12-31 45USD
CashEquivalents5,488,2452019-12-31 1USD
RepairsAndMaintenanceExpense5,433,5252025-06-30 26USD
CashAndBankBalancesAtCentralBanks5,080,6132019-12-31 5USD
OtherCurrentAssets5,000,0002020-12-31 1USD
CurrentProvisionsForEmployeeBenefits4,964,4212025-12-31 45USD
NoncurrentPayablesToTradeSuppliers4,785,3002025-09-30 6USD
OtherFinanceIncomeCost-4,717,2562025-12-31 62USD
NetDeferredTaxAssets4,535,7522020-06-30 7USD
AdvertisingExpense4,509,1832025-06-30 26USD
GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities4,406,9322025-12-31 50USD
CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments-4,222,1302017-06-30 1USD
OtherReceivables4,132,7452024-03-31 19USD
FinanceIncomeReceivedClassifiedAsOperatingActivities4,125,6602025-12-31 41USD
CashFlowsFromUsedInInvestingActivities-4,068,2172025-12-31 48USD
TravelExpense3,888,9912025-06-30 26USD
RiskExposureAssociatedWithInstrumentsSharingCharacteristic3,805,3252025-06-30 13USD
DeferredTaxExpenseIncome-3,708,6712025-12-31 54USD
DeferredTaxExpenseIncomeRecognisedInProfitOrLoss3,708,6712025-12-31 45USD
InvestmentProperty3,675,4932033-09-30 23USD
ProfitLossBeforeTax-3,627,4962025-12-31 68USD
AccountingProfit-3,627,4962025-12-31 28USD
DepreciationPropertyPlantAndEquipment3,381,9132025-12-31 34USD
AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables-3,249,1142025-12-31 48USD
IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment3,222,0442024-06-30 4USD
FeeAndCommissionExpense3,208,9332025-06-30 44USD
CurrentInventoriesInTransit3,054,6362025-12-31 45USD
AdjustmentsForAmortisationExpense3,030,3952025-12-31 48USD
InsuranceExpense3,027,8032025-06-30 26USD
CurrentLeaseLiabilities2,765,0722025-12-31 40USD
TaxExpenseIncomeAtApplicableTaxRate2,726,9772025-12-31 54USD
InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod2,650,9342024-03-31 25USD
LiabilitiesIncurred2,625,3352021-06-30 1USD
CashAdvancesAndLoansMadeToRelatedParties2,621,6472018-06-30 3USD
CurrentDeferredIncomeIncludingCurrentContractLiabilities2,497,9442025-12-31 30USD
CurrentAdvances2,497,9442025-12-31 27USD
LicenceFeeIncome2,399,2122025-09-30 13USD
BiologicalAssets2,363,5682025-12-31 61USD
PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities2,238,2862025-12-31 41USD
AdjustmentsForDepreciationExpense2,226,2042025-12-31 48USD
FinanceIncome2,194,2082019-12-31 6USD
IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment-2,164,1562021-06-30 2USD
InterestIncomeOnOtherFinancialAssets2,158,8482019-12-31 6USD
AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment2,145,9992025-12-31 14USD
TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures2,105,7532023-06-30 16USD
CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations-2,076,4402025-12-31 2USD
EffectOfExchangeRateChangesOnCashAndCashEquivalents-2,069,7222025-12-31 48USD
CashFlowsFromUsedInInvestingActivitiesContinuingOperations-1,991,7772025-12-31 2USD
RevaluationIncreaseDecreasePropertyPlantAndEquipment-1,985,8062023-06-30 1USD
CurrentTaxAssets1,908,3442025-12-31 45USD
NumberOfInstrumentsOrInterestsIssuedOrIssuable1,875,0002020-12-31 2pure
AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill1,853,9502025-12-31 14USD
TaxEffectFromChangeInTaxRate1,780,9622021-06-30 16USD
DepreciationRightofuseAssets1,760,8062025-12-31 40USD
OtherCurrentFinancialAssets1,515,1452025-12-31 45USD
OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities-1,511,4982025-12-31 48USD
OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax-1,467,3492023-06-30 34USD
CurrentAgriculturalProduce1,464,6092025-12-31 32USD
NoncurrentContractLiabilities1,436,9122025-12-31 22USD
NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime1,436,9122025-12-31 22USD
NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities1,436,9122025-06-30 5USD
OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation-1,282,7192023-06-30 34USD
NoncurrentProvisions1,267,5722025-06-30 23USD
NoncurrentTradeReceivables1,266,7382025-12-31 11USD
OtherLongtermProvisions1,238,1222025-12-31 22USD
NumberOfOutstandingShareOptions1,200,0002019-12-31 1USD
AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss1,104,8492025-12-31 26USD
OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome1,086,0522025-06-30 31USD
KeyManagementPersonnelCompensation1,072,9342025-12-31 48USD
KeyManagementPersonnelCompensationShorttermEmployeeBenefits1,072,9342025-12-31 48USD
ExpenseFromSharebasedPaymentTransactionsWithEmployees1,069,6292019-12-31 4USD
CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations-1,066,3292025-12-31 2USD
AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets1,036,2762025-09-30 32USD
GainRecognisedInBargainPurchaseTransaction1,032,3272024-06-30 1USD
IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl-980,3222022-06-30 1USD
NumberOfShareOptionsGrantedInSharebasedPaymentArrangement971,0722021-06-30 4USD
MinimumFinanceLeasePaymentsPayable935,0872019-06-30 3USD
IncreaseDecreaseThroughTreasuryShareTransactions-926,8992025-06-30 28USD
PaymentsToAcquireOrRedeemEntitysShares926,8992025-06-30 27USD
ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod900,0002024-06-30 5USD
PaymentsForDevelopmentProjectExpenditure894,4742025-12-31 48USD
IncreaseDecreaseThroughAcquisitionOfSubsidiary870,7952025-12-31 2USD
MinimumFinanceLeasePaymentsPayableAtPresentValue848,8172019-06-30 3USD
MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease848,8172019-06-30 3USD
AcquisitionsThroughBusinessCombinationsInvestmentProperty816,5762024-06-30 6USD
IncreaseDecreaseInFinancialAssets-773,5912025-12-31 10USD
FuelAndEnergyExpense765,4672025-06-30 26USD
RevenueFromSaleOfAgriculturalProduce-760,5242025-12-31 38USD
PurchaseOfInvestmentProperty758,0632020-12-31 2USD
PaymentsFromChangesInOwnershipInterestsInSubsidiaries724,4292022-03-31 3USD
IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome712,4582023-06-30 23USD
IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome-703,0872023-06-30 34USD
AdministrativeExpense680,9362021-06-30 14USD
TaxEffectOfRevenuesExemptFromTaxation2011598,9592023-12-31 5USD
RevenueFromRoyalties549,1332025-12-31 54USD
NoncurrentProvisionsForEmployeeBenefits534,0382020-06-30 5USD
IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset-501,4782024-06-30 15USD
ProceedsFromSaleOrIssueOfTreasuryShares488,2932025-12-31 1USD
NoncurrentFinanceLeaseLiabilities462,8702019-06-30 3USD
CurrentTaxLiabilitiesCurrent452,8002025-06-30 13USD
ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests449,9432025-12-31 4USD
NoncurrentFinancialAssetsAvailableforsale444,4102024-03-31 28USD
ComprehensiveIncomeFromContinuingOperationsAttributableToNoncontrollingInterests435,9812025-12-31 4USD
IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputAssets400,0002021-06-30 1USD
UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised400,0002023-06-30 2USD
MiscellaneousOtherOperatingExpense393,8552025-06-30 26USD
CurrentFinanceLeaseLiabilities385,9472019-06-30 3USD
IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset-375,5732025-12-31 45USD
ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod369,0262025-12-31 68USD
AcquisitionsThroughBusinessCombinationsOtherProvisions355,8982024-06-30 8USD
InterestCostsCapitalised336,7762025-12-31 21USD
NoncurrentReceivables326,3802023-03-31 11USD
GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets292,3442025-12-31 42USD
GainsLossesOnFairValueAdjustmentBiologicalAssets292,3442025-12-31 63USD
SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates279,6932020-12-31 1shares
CurrentPrepaidExpenses251,5902025-06-30 22USD
OtherCurrentPayables218,8772025-12-31 45USD
ShorttermDepositsNotClassifiedAsCashEquivalents212,7032023-06-30 25USD
OtherOperatingIncomeExpense-148,8852025-12-31 68USD
CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime138,0802024-09-30 16USD
DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity134,7702025-06-30 10USD
ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod-133,0792023-06-30 3USD
AdditionalLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination122,9502020-06-30 3USD
ContingentLiabilitiesRecognisedInBusinessCombination122,9502020-12-31 4USD
AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill122,3052024-06-30 4USD
ProfitLossAttributableToNoncontrollingInterests-120,3472025-09-30 64USD
ComprehensiveIncomeAttributableToNoncontrollingInterests-110,5252025-09-30 64USD
AdjustmentsForProvisions109,1862025-12-31 48USD
GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod-102,3972025-12-31 29USD
OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities101,8832021-06-30 7USD
FutureFinanceChargeOnFinanceLease86,2702019-06-30 3USD
IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill74,8592025-12-31 14USD
DividendsPaidClassifiedAsFinancingActivities72,0512025-06-30 19USD
DividendsPaid72,0512025-06-30 17USD
CommunicationExpense67,4172019-06-30 4USD
TaxEffectOfTaxLosses59,8792018-06-30 2USD
IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment-55,4892025-12-31 14USD
GainsLossesOnExchangeDifferencesOnTranslationNetOfTax-44,1192025-12-31 66USD
OtherComprehensiveIncome-44,1192025-12-31 66USD
OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax-44,1192025-12-31 68USD
NoncurrentAdvances41,2372025-09-30 16USD
IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions-35,4392025-06-30 20USD
CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings-32,8382022-06-30 24USD
PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities32,6172025-12-31 48USD
IncreaseDecreaseThroughExerciseOfOptions30,0052018-06-30 3USD
ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities26,5042025-12-31 47USD
DisposalsPropertyPlantAndEquipment26,5042025-12-31 13USD
AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets-23,9022025-12-31 48USD
IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets-22,0432022-09-30 18USD
CurrentTaxAssetsNoncurrent19,4352025-12-31 45USD
OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations-11,0432024-09-30 27USD
AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates-7,8532022-12-31 1USD
IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill-2,6022025-09-30 1USD
CurrentGovernmentGrants1,9552020-12-31 13USD
RevenueFromGovernmentGrants8052021-12-31 27USD
GovernmentGrants7842021-06-30 16USD
NoncurrentGovernmentGrants7842021-06-30 16USD
IncreaseDecreaseThroughSharebasedPaymentTransactions5332025-12-31 42USD
OtherNoncurrentFinancialAssets492025-12-31 45USD
DescriptionOfOptionLifeShareOptionsGranted102019-12-31 2Y
WeightedAverageSharePriceShareOptionsGranted201952019-12-31 2USD/shares
ExercisePriceShareOptionsGranted201952023-06-30 7USD/shares
WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement201952019-12-31 1USD/shares
BasicEarningsLossPerShare-32025-12-31 64USD/shares
DilutedEarningsLossPerShare-32025-12-31 60USD/shares
BasicEarningsLossPerShareFromDiscontinuedOperations-32025-12-31 4USD/shares
DilutedEarningsLossPerShareFromDiscontinuedOperations-32025-12-31 4USD/shares
WeightedAverageFairValueAtMeasurementDateShareOptionsGranted22019-12-31 2USD
ApplicableTaxRate02021-06-30 27pure
DescriptionOfExpectedVolatilityShareOptionsGranted02019-12-31 2pure
PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets02021-06-30 2pure
BasicAndDilutedEarningsLossPerShare-02021-06-30 18USD/shares
DescriptionOfDiscountRatesAppliedToCashFlowProjections02020-06-30 2pure
BasicEarningsLossPerShareFromContinuingOperations-02025-12-31 4USD/shares
DilutedEarningsLossPerShareFromContinuingOperations-02025-12-31 4USD/shares
ClosingForeignExchangeRate02022-07-12 1USD
WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS1602023-06-30 4pure
DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections02024-06-30 6pure
ParValuePerShare02020-06-30 1USD/shares
DescriptionOfRiskFreeInterestRateShareOptionsGranted02022-07-12 4pure
ExpectedDividendAsPercentageShareOptionsGranted02019-12-31 2pure
KeyManagementPersonnelCompensationSharebasedPayment02025-12-31 40USD

What to be careful about

What this model itself distrusts about BIOX's figures. Written by the derivation as it ran, not added afterwards.